The Genome In­sti­tute of Sin­ga­pore in­tro­duces cus­tom­ized can­cer treat­ment

BioSpectrum (Asia) - - Academic News -

The Genome In­sti­tute of Sin­ga­pore (GIS) has launched a new lab­o­ra­tory that will help pro­vide cus­tomised, cut­ting-edge treat­ment for can­cer pa­tients. The lab, set up in part­ner­ship with lo­cal health­care bio­an­a­lytic firm In­vit­rocue, will de­velop mod­els of can­cer­ous tu­mours us­ing cells from pa­tients, and utilise tech tools like ar­ti­fi­cial in­tel­li­gence and data min­ing to trawl through ge­netic in­for­ma­tion found in cell mod­els.

It will then iden­tify novel biomark­ers or genes linked to the ill­ness to mea­sure drug re­sis­tance and re­sponses to treat­ment. The lab’s ef­forts will help pro­vide a real-time sta­tus up­date for the treat­ment a pa­tient is un­der­go­ing in a clinic. GIS comes un­der the Agency for Science, Tech­nol­ogy and Re­search (A*Star). The lab, called the GIS-IVQ Joint Lab­o­ra­tory, will be housed at the Genome build­ing in Biopo­lis, and will carry out re­search into head and neck can­cer, col­orec­tal can­cer, liver can­cer, and triple-neg­a­tive breast can­cer, which makes up 10 per cent of all breast can­cers in Sin­ga­pore. It will cost about $10 mil­lion to op­er­ate over the next few years. The lab will be the first in the Asi­aPa­cific re­gion to fo­cus on the in­te­gra­tion of phe­no­typic data and ge­nomic data.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.